Locomotor activity and food and water consumption are potentially indices of post-operative pain in laboratory rodents, but it is important to establish whether these variables are directly affected by opioid analgesics or by halothane anaesthesia in normal rats. The effects of three opioids, buprenorphine, nalbuphine and butorphanol administered alone or following halothane anaesthesia, were studied in groups of normal non-operated adult Wistar rats.
Pain must be assessed if it is to be treated effectively and in man a number of methods have been described for the assessment of pain (Alexander & Hill, 1987) . Assessment of pain in Received 24 September 1990; accepted 11 October 1991 animals remains highly subjective but in recent years laboratory researchers and veterinary surgeons have become increasingly interested in trying to quantify post-operative pain in animals (Morton & Griffiths, 1985; Barclay et al., 1988 ). An objective, rather than subjective, index of pain would lead to better methods of assessing the effects and duration of analgesics administered to control pain following experimental procedures.
A review of recent literature yielded only 2 reports of pain being objectively assessed in laboratory rodents. Chudler and Dong (1983) observed motor behaviour and body weight changes in rats after sciatic nerve transection. Leese et al. (1988) constructed a scale to assess the level of post-operative analgesia produced in rats by varying doses of the opioid analgesic buprenorphine. Each rat's response to toe and tail pinch tests was graded from 0-3, the animal's score plus its appearance, behaviour and eating habits were then used to determine whether adequate analgesia had been produced.
Various investigators have suggested that an animal's motor behaviour reflects the level of pain it may be experiencing (Chudler & Dong, 1983; Wright et al., 1985; Flecknell, 1987) but there have been few published reports that directly measured spontaneous activity in animals and use this as an objective measurement of pain. Wright et al. (1985) and Morton and Griffiths (1985) both report that a reduction in body weight and a loss of appetite have been seen in rodents post -operatively. It has been suggested that if administration of an analgesic results in a return of these variables to preoperative levels, Effects of analgesicsin rats then this would support the view that the changes were related to pain (Morton, 1985) .
One major problem encountered when using these variables to assess pain is that the analgesics may directly affect the variables being observed. Opioid analgesics have been widely reported to affect food and water intake (Reid, 1985) , spontaneous motor activity (Fog, 1970; Cowan et al., 1977a; Schmidt et al., 1985) and the cardiovascular system (Bovill et al., 1984) . However, many of these reports only studied short-term effects of high doses of compounds and provide no information about the likely effects of clinical dosing regimens. Despite the fact that nearly all analgesics are tested on animals prior to their use in man (Baumberger, 1983) , very little is known about the effects of clinical doses of analgesics on physiology and behaviour in normal rodents.
Buprenorphine, nalbuphine and butorphanol are all agonist-antagonist opioid analgesics. These drugs were chosen for investigation because they reflect the analgesics currently being administered post-operatively to rodents. It has been widely reported that buprenorphine has a much longer duration of action than most other opioid analgesics (Downing et al., 1977; Schmidt et al., 1985a) . This property, coupled with the reports that buprenorphine has fewer cardiovascular and respiratory side-effects (Taylor & Houlton, 1984) makes buprenorphine a useful post-operative analgesic. A number of different dose rates of buprenorphine have been reported to provide effective analgesia in animals (Cowan et al., 1977b; Downing et al., 1977; Heel et 01. , 1979) . These dose regimens are based upon the results of experimental analgesiometry and may not necessarily be appropriate for clinical use. We decided to use low doses of buprenorphine O' 05 and 0·01 mg/kg in this experiment because these are the doses that are given regularly to post-operative cases in this institute. These dose rates represent about 5010 of the EDso of bupre-,norphine in a tail flick test, or 50010of the EDso in a mouse writhing test (Cowan et al., 1977b) .
Schmidt et 01. (1985b) state that nalbuphine is a potent analgesic with a high therapeutic index 181 and fewer behavioural effects at analgesic doses than other mixed agonist/antagonist opioids. A clinical dose rate for nalbuphine in the rat does not appear to have been determined so a number of different dose rates were evaluated. The durationoI action of nalbuphine is only 3-4 h (Schmidt et al., 1985b) , so that repeat dosing would be needed to provide effective postoperative analgesia. We, therefore, investigated the effects of repeat doses of nalbuphine for a period of either 12 or 24 h.
Butorphanol is a potent analgesic with few serious side-effects, a very low abuse potential (Taylor, 1985) and in the UK is currently not subject to any controlled drug regulations. This gives butorphanol great potential for use in research establishments and veterinary practices. A dose of 0'4 mg/kg was adopted and repeat doses were given at 5 h intervals after consideration of the available pharmacological data (Pircio et al., 1976; Heel et 01., 1978) .
The present experiments measured the effects of these 3 commonly used agonist/antagonist opioid analgesics, at a number of dose rates and dose regimens, on spontaneous locomotor activity and on food and water consumption in normal rats.
Materials and methods

Experimental design
Male Wistar outbred rats, weighing between 250-350 g, obtained from this Institute's Specific Pathogen Free Unit were used. Each group of rats received single or multiple doses of either nalbuphine, butorphanol or buprenorphine, either alone or following halothane anaesthesia. Four control groups of rats received injections of saline in identical regimens as the analgesic treated groups. The treatments given to each of the groups of rats are summarized in Table 1 . The animals were housed in a room which was remote from the main area of the animal unit to avoid disturbance due to external factors.
Room temperature was controlled at 20 ± 2°C and a 9 h: 15 h light-dark cycle was maintained. The room lighting was automatically switched on at 0800 h and off at 1700 h. Animals received Ltd, Essex, England) and water ad libitum. All animals underwent a 2-week period of acclimatization to single housing and daily handling and weighing prior to study. Food and water consumption was monitored by weighing the animals' food hoppers and water bottles between 0900 and 1000 h each day. Locomotor activity was monitored using an array of infra-red beams coupled to a computer recording system. The animals were housed individually in polycarbonate cages (590 x 385 x 270 mm) (Type 4R, Biotech Division, Steven Clark Fabrications, Clackmannanshire, Scotland). Each cage was placed within an array of 4 x 3 infra-red beams, which divided the cage into 12 areas, each measuring approximately 15x 12cm. The beams were connected via a purpose built interface to an Acorn Archimedes microcomputer (Acorn Computers Ltd, Cambridge, England). As the animal moved in the cage the computer recorded which beams had been broken in the preceding second and the information was stored on computer-disc. Monitoring was continued for a 23-h period normally starting at 1000h. The stored data were then analysed to determine the number of movements made in each l-h period. When this data is graphed the total number of movements made in 1 h are plotted at the start of the collection period. Repeated interruption of the same beam was not counted as a movement, so that motion between 15x 12 cm sections was recorded, rather than small movements such as . grooming which would occur whilst the animal remained in the same location. The drugs used were nalbuphine (Nubain, Du Pont (UK) Limited Pharmaceuticals, Hertfordshire, England), butorphanol (Torbutrol, C-Vet Ltd, Bury St Edmunds, England) and buprenorphine (Temgesic, Reckitt & Colman (PL), Pharmaceutical Division, Hull, England). On the day of treatment the drug was diluted with saline to ensure that the volume that was administered was around o· 3 ml. Control animals were injected with O' 3 ml saline. All injections were given subcutaneously using insulin syringes (B-D Lo-Dose, Becton Dickinson & Co., New Jersey, USA). All the groups that required halothane anaesthesia were induced with 4070halothane in an anaesthetic chamber and maintained for 20 min with I· 5-2070 halothane in oxygen. During anaesthesia the animals' rectal temperature was maintained at 38°e using a thermostatically controlled heating blanket and during a 30-min recovery period they were placed in an incubator maintained at 30°e. Following this, the animals were replaced in their cages. Locomotor activity and food and water intake were monitored as described earlier.
Statistical methods
Food and water consumption before and after treatment were compared within groups of rats using Student's paired t-tests. The relative change in food and water intake between analgesic and saline treated groups of rats was examined by calculating the ratio of post-treatment intake to pre-treatment intake, and compared between groups using Student's unpaired t-test.
The measurements of locomotor activity were examined and a number of summary measures were produced, as proposed by Mathews et al. (1990) . In order to focus on those time-periods which were likely to be most sensitive to disturbances of activity, 3 time-periods of 2 h, one during the light and 2 during the dark phase of the animals' photoperiod were selected (see 183 Tables 4-6). The time intervals were chosen to coincide with the periods immediately following administration of the drug. Each animal's activity in each of the 3 periods was compared with its activity in the same time-period on the previous day, using Student's paired t-test after log-transformation of the data.
To enable comparison between groups of rats, a similar approach to that described by Barclay et al. (1988) was adopted. The log ratio of the activity after treatment to the activity during the equivalent time-period on the day prior to treatment was calculated:
Control activity during period I A positive ratio indicates increased activity relative to the pre-treatment level, a negative ratio indicates depressed activity. These ratios were compared between analgesic and saline treated groups using Student's unpaired t-test.
Results
Food and water consumption for the 24-h periods before and after treatment together with levels of significance are summarized in Tables  2 and 3 . Significance levels for within-group comparison of pre-and post-treatment intake using Student's paired t-test: *P<O·05; "P<O'OI; "*P<O·OOI. + Results of the comparison of the ratio of the post-/pre-treatment food intake between a group of animals and the appropriate saline control group. P<0.05. Food intake Injection of saline without anaesthetic caused an increase in food intake, which was not significant in the group which received repeated injections. Halothane anaesthesia caused a reduction in food intake. When compared with these baselines, the analgesics all either caused no significant change in intake, or a significant reduction in intake. The ratio of post-/pre-treatment food intake in the rats that received a single injection of either buprenorphine (TO1, T05), nalbuphine (NI, N2) or butorphanol (B) was significantly (P<O·005) lower than the same ratio for the saline control group (S). The ratio of post-Ipre-treatment food intake in the rats which received 3 doses of nalbuphine (N3) was also significantly (P<0·05) lower than the same ratio for the saline control group (S3). A decrease in food intake that was significantly (P <O'005) greater than that caused by halothane (H) alone was seen in the groups that received the higher doses of buprenorphine (HT05, H2T05) ( Fig. I) . Halothane and 3 doses of butorphanol (HB3) also caused a significantly greater decrease in food intake than its control group halothane and 3 doses of saline (HS3). * * * HTOS H2T01 H2TQ5 Fig. 1 . The ratio of post-/pre-treatment food and water intake in 6 groups of rats. Values are mean ± SO. S = saline O' 3 ml sic 1000h (n = 10);T05 = buprenorphineO'OS mglkgs/c 1000h (n = 12); H = halothane 1000 h (n = 10); HT05 = halothane 1000 h + buprenorphine 0·05 mg/kg sic 1000 h (n = 10); H2TOI + halothane 1000 h + buprenorphine 0·01 mg/kg sic 1000 hand 1700 h (n = 9); and H2T05 = halothane 1000 h + buprenorphine O'05 mg/kg s/ c 1000 hand 1700 h (n= 10). ·Post-treatment intake is significantly (P<0'05) different from pre-treatment intake. EI Food; 0 water.
Water intake
The control groups showed either no significant change, or a significant reduction (halothane and repeated injections HS3 HS6) in water intake. A significant reduction in water intake was seen following halothane and 2 doses of buprenorphine (H2TOI) but this reduction was not significantly greater than the one following halothane anaesthesia alone. Only one of the experimental groups differed significantly from its control condition; the group which received a single 1 mg/kg dose of nalbuphine (NI) showed a reduction in intake. However, neither a smaller nor a larger dose had this result.
Locomotor activity
The number of movements in each time-period differed considerably both between individual rats and between groups. The logarithms of the ratios of post-/pre-treatment activity levels in the 3 time-periods of 2 h are summarized in Tables 4-6. 
Single administration of analgesics
A single dose of saline produced no significant changes in activity levels in 2 of the time-periods, and a small but significant depression in activity during the first dark period, 1700-1900 h. Single doses of nalbuphine O' 5 mg/kg and 2· 0 mg/kg (N, N2) had no significant effects on activity when these groups were compared with their saline control group (S). However, rats that received butorphanol (B), buprenorphine (TOI, T05) and nalbuphine (Nl) all had increased activity during one or more of the 3 time-periods when compared to the saline control group (S) ( Table 4 ; Fig. 2 ).
Repeated administration of analgesics
Rats which received 3 doses of saline (S3) showed no significant change in activity levels during any of the time-periods (Table 5 ). Groups of animals which received either 3 doses of nalbuphine (N3) or 3 doses of butorphanol (B3) had significantly greater activity than the saline control group (S3) in the time-period immediately following administration of the first dose 1100-1300 h, but had no significant effect on locomotion in the other 2 time-periods.
Single administration of analgesic/halothane anaesthesia
Halothane anaesthesia alone (H) had no significant effects on activity levels during any of the time-periods (Table 4 ). Groups that had halothane anaesthesia followed by one or 2 injections of buprenorphine (HT05, H2TOI and H2T05) had significantly greater activity than the halothane control group (H) in one or more time-periods.
Repeated administration of analgesics/halothane anaesthesia
Halothane followed by three doses of saline (HS3 ; Table 5 ) caused a significant decrease in activity following the third dose of saline (1800-2000 h). When compared with this control group, halothane and 3 doses of nalbuphine (HN3) had a significantly greater activity for the period following the first injection, 1100-1300 h and for the period following the final injection 1800-2000 h. Halothane and 3 doses of butorphanol (HB3) had a significantly greater activity for the period following the final injection 1800-2000 h and a significantly reduced activity for the time interval 5-6 h after the final injection 0100-0300 h when compared with the saline control group (HS3).
Halothane and 6 doses of saline (H6S ; Table  6 ) caused a significant decrease in activity at the 2000-2200 hand 0300-0500 h time-periods. These time-periods follow the third and fifth saline injections, respectfully. When compared with this saline treated control group rats which received halothane and 6 doses of nalbuphine (HN6) had significantly greater activity at all time-periods (1100-1300 h, 2000-2200 hand 0300-0500 h). The group of rats that received halothane and then 6 doses of nalbuphine (HN6) had an unusual activity pattern, following each injection of nalbuphine (1 mg/kg), a rapid and large increase in activity levels occurred for a period of 1-2 h (Fig. 3) , this increase was followed by a depression of activity to below pretreatment levels, No statistical analysis is available on this depressed portion of the data because the time-periods for study were chosen in the expectation that any effect would be present during the first 2 h post-treatment.
Discussion
The main aim of this study was to see how clinical analgesic regimens and anaesthesia affect potential pain indicators, as any such effect must be taken into consideration when assessing the need for, and effectiveness of, such treatments.
With the exception of nalbuphine (0' 5 mg/kg) all of the analgesics tested caused a reduction in the rats' food intake (Tables 2 and 3 ). Groups of animals that had repeat doses of opioids 187 showed a larger reduction in their food intake than groups that received a single dose of the same analgesic. Anaesthesia resulted in a further decrease in food consumption. Although the change in food intake was statistically significant, the magnitude of the reduction was less than 10070 of pre-treatment intake in the single administration group. Such a small change would be unlikely to mask any substantial reduction caused by pain. In contrast, the reduction in food intake following halothane and 2 doses of buprenorphine (H2T05) was 52%. Such a reduction could make it difficult to assess any effects of pain on food intake. Furthermore, a reduction of this magnitude is of obvious clinical relevance. Even small reductions in food intake post-operatively are undesirable and in order to minimize these effects opioids should only be given for the period when analgesia is needed.
Water consumption over the 24 h period following treatment was significantly (P<0'05) depressed in the 2 control groups that received halothane and repeated doses of saline (HS3, HS6). The groups of rats that received repeated doses of analgesic after halothane anaesthesia all had a greater reduction in water intake than those groups that only received a single dose of analgesic. All of the reductions in water intake were less than 15070 of the pre-treatment intake. The rats that received 3 doses of saline (HS3) had an average decrease in intake of 2 ml and those receiving 6 doses (HS6) had an average decrease of 3 ml. Part of this reduction in water consumption may simply be a response to the injection of a total volume of saline of O·9 ml and 1. 8 ml, respectively. If water intake is used as an index of post-operative pain it is important that any intra-operative and post-operative fluid therapy is taken into account. Activity levels were affected by the majority of the analgesic regimens studied. Buprenorphine, even at the very low doses used in this study greatly increased spontaneous locomotor activity. A single dose of buprenorphine (0' 05 mg/kg) at 10·00 h caused an increase in activity in 8 h (Fig. 2) . Although this effect may not be thought particularly undesirable, it could be misleading if the rats' activity is being used to assess the level of pain or degree of analgesia. Buprenorphine may also affect the circadian rhythmicity of the rats' activity pattern, since it can be seen from Fig. 2 that the rats' normal evening increase in activity starts an hour earlier on the treatment day and the decrease in activity before the onset of the light phase of the photoperiod occurs earlier.
In contrast to buprenorphine, a single dose of nalbuphine (2 mg/kg) only caused a small increase in activity, but a single injection of the lower dose of nalbuphine 1mg/kg did increase activity. This effect may be due to the mild stimulatory effects of na]buphine counteracting the slight depressant effect noted following administration of saline (Table 4 ). None of the doses of na]buphine used caused prolonged increases in activity. Repeated dosing every 4 h for a period of 24 h caused a significant increase in activity at all the time points studied when compared with saline injections at the same intervals (Table 6 ). Nalbuphine appears to be rapidly absorbed after subcutaneous injection, since the increase in activity is seen immediately following the drug's administration, but its duration of action appears to be shorter than anticipated and may only be 2-3 h. Like nalbuphine, a single dose of butorphanol (0'4mg/kg sic) only caused a small increase in activity during the first few hours following injection. However, repeated dosing with butorphanol (0' 4 mg/kg s/ c, 3 times at 5 hourly intervals) caused repeated periods of elevation in activity levels.
In summary, all of the mixed agonistantagonists analgesics studied have detectable effects on locomotor activity and food consumption in rats. It is possible that opioid analgesics may cause different behavioural effects in animals that are experiencing pain in comparison with the effects in normal pain-free subjects (Hall & Clarke, ]989). Although the effects of surgical stress on many metabolic systems have been widely reported (Gryglewski et al., ]985; Lacoumenta et al., 1986) , the interactions between pain and opioid induced behavioural changes remain speculative. Until further studies have been undertaken into the interaction between the presence and absence of post-operative pain and the effects of opioids, it should be assumed that opioids may produce similar effects in animals which have undergone surgery. If these variables are used to assess the adverse effects of surgery, great care should be taken not to assume that analgesic cover is adequate because the animals' activity is normal or to increase analgesic doses because food consumption has decreased. The effects of opioid administration on food intake indicates that unnecessary administration of some opioid regimens can be detrimental to the animal and reinforces the need for an objective method of pain assessment so that analgesics can be administered only when they are required. In contrast to the effects of food intake, water consumption was either unaffected or only slightly affected by analgesics. Previous studies have shown that surgical procedures depress water intake in rats (FlecknelI & Liles, ]991). Water consumption is a simple variable to measure in rats and could be a useful means of assessing the effects of postoperative analgesics.
